SXTC's Business Model
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
| Sector & Industry | Healthcare / Drug Manufacturers - Specialty & Generic |
| Website | https://www.sxtchina.com |
| CEO (Chief Executive Officer) | Feng Zhou |
| Number of Employees | |
| IPO date | January 4, 2019 |
SXTC Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | CN |
| Address | 178 Taidong Road North |
| City | Taizhou |
| State | None |
| Phone | 86 523 8629 8290 |
| Zip Code | 225300 |
| Other Identifiers | |
| CIK | 0001723980 |
| ISIN | VGG2161P1650 |
| CUSIP | G2161P165 |
| Open | 2.1 |
| Previous Close | 2.13 |
| Volume | 53.09 Thou. |
| Average Volume | 292.5 Thou. |
| Day’s Range | 1.89 – 2.1426 |
| 52 Week Range | 1.88-1047 |
| MA (50) | 35.7679 |
| MA (200) | 185.70798 |
| Market Cap | 1.61 Mil. |
| Shares Out. | 853.5 Thou. |
| Earnings Date | Jul 17, 2023 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
